MedPath

To compare the role of hydroxyurea (A medicine use in treatment) and conventional managment versus conventional managment alone to decrease cell count in children of acute leukemia (A type of blood cancer with increase in cell count more then 1 lakh/cmm.

Not Applicable
Completed
Conditions
Health Condition 1: null- leukemia
Registration Number
CTRI/2012/10/003050
Lead Sponsor
o primary sponcer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
48
Inclusion Criteria

•New case of acute leukemia with hyperleukocytosis

•Parent consent for trial

•Parent willing to take treatment for their child in our centre

Exclusion Criteria

•Refusal of consent

•Relapse of disease

•Age less then 1 year or more then 12 year

•Case treated outside

•Hyperleukocytosis associated with disease other than acute leukemia

•Hyperleukocytosis presented with acute renal failure, intracranial bleed and requiring ventilation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath